Modulation of Hedgehog Signaling for the Treatment of Basal Cell Carcinoma and the Development of Preclinical Models (original) (raw)
Identification of a small molecule inhibitor of the hedgehog signaling pathway: Effects on basal cell carcinoma-like lesions
Lee Ling Chai
Proceedings of The National Academy of Sciences, 2003
View PDFchevron_right
Hedgehog signaling pathway and its targets for treatment in basal cell carcinoma
Enrico Smaele
Journal of Experimental Pharmacology, 2012
View PDFchevron_right
Advances in the Treatment of Basal Cell Carcinoma: Hedgehog Inhibitors
rene francisco Gonzalez
Seminars in Oncology, 2012
View PDFchevron_right
The Role of the Hedgehog Signaling Pathway in the Development of Basal Cell Carcinoma and Opportunities for Treatment
Ivor Caro
Clinical Cancer Research, 2010
View PDFchevron_right
High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature
Terenzio Cosio
Chemotherapy
View PDFchevron_right
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
Patricia Lorusso, Bert Lum, Walter Darbonne
New England Journal of Medicine, 2009
View PDFchevron_right
Novel Hedgehog pathway targets against basal cell carcinoma
Po-Lin So
Toxicology and applied pharmacology, 2007
View PDFchevron_right
Review: Targeting the Hedgehog pathway in cancer
Naoko Takebe
Therapeutic Advances in Medical Oncology, 2010
View PDFchevron_right
Hedgehog signaling pathway: A novel target for cancer therapy: Vismodegib, a promising therapeutic option in treatment of basal cell carcinomas
Afroz Abidi
Indian Journal of Pharmacology, 2014
View PDFchevron_right
Hedgehog signalling pathway: Carcinogenesis and targeted therapy
Mohamad Ebrahimi
Iranian Journal of Cancer Prevention, 2013
View PDFchevron_right
Hedgehog antagonist GDC-0449 is effective in the treatment of advanced basal cell carcinoma
Shivan Amin
The Laryngoscope, 2010
View PDFchevron_right
Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors
Maikel Peppelenbosch
Drug Resistance Updates, 2012
View PDFchevron_right
Hedgehog pathway inhibitors promote adaptive immune responses in Basal cell carcinoma
Atsushi Otsuka, Phil Cheng
Clinical cancer research : an official journal of the American Association for Cancer Research, 2015
View PDFchevron_right
Clinical implications of hedgehog signaling pathway inhibitors
Dongsheng Gu
Chinese Journal of Cancer, 2011
View PDFchevron_right
Basal cell carcinoma — molecular biology and potential new therapies
Daniel Hohl
Journal of Clinical Investigation, 2012
View PDFchevron_right
Anticancer Section / Review High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature
Terenzio Cosio
2020
View PDFchevron_right
Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma
Nancy Nix
Journal of the Advanced Practitioner in Oncology, 2014
View PDFchevron_right
Hedgehog beyond medulloblastoma and basal cell carcinoma
Stephan Teglund
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
View PDFchevron_right
MK-4101 - a potent inhibitor of the hedgehog pathway - is highly active against medulloblastoma and basal cell carcinoma
Lucia Di Marcotullio
Molecular cancer therapeutics, 2016
View PDFchevron_right
Small-Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics
Stefan Peukert
ChemMedChem, 2010
View PDFchevron_right
Melanoma and Cutaneous Malignancies Characterization andManagement of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
Rogerio I Neves
2016
View PDFchevron_right
Update on Hedgehog Pathway Inhibitor Therapy for Patients with Basal Cell Naevus Syndrome or High-frequency Basal Cell Carcinoma
Kelly Sinx
Acta Dermato-Venereologica
View PDFchevron_right
A Practical Guide for the Follow‐Up of Patients with Advanced Basal Cell Carcinoma During Treatment with Hedgehog Pathway Inhibitors
Efthymia Soura
The Oncologist
View PDFchevron_right
Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer
Ram Mahato
Scientific Reports, 2017
View PDFchevron_right
Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
Susana Puig
The oncologist, 2016
View PDFchevron_right
Hedgehog Signaling: An emerging targeting therapy in Cancer
Urja Desai
Asian Journal of Pharmacy and Pharmacology
View PDFchevron_right
Hedgehog-Gli Signaling Pathway Inhibitors as Anticancer Agents
Neeraj Mahindroo
Journal of Medicinal Chemistry, 2009
View PDFchevron_right
The role of the Hedgehog signaling pathway in cancer A comprehensive review
BJBMS Journal
View PDFchevron_right
Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade
Sakshi sinha
Proceedings of the …, 2009
View PDFchevron_right
Basal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches
Dario Didona
Biomedicines, 2020
View PDFchevron_right
Biochemical pathways and targeted therapies in basal cell carcinoma: A systematic review
Bao anh Tran
Journal of Surgical Dermatology, 2016
View PDFchevron_right
Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome
Omar Ozgur
American Journal of Ophthalmology, 2015
View PDFchevron_right
Recent Advances in Signaling Pathways Comprehension as Carcinogenesis Triggers in Basal Cell Carcinoma
Carolina Constantin
Journal of Clinical Medicine
View PDFchevron_right
A paracrine requirement for hedgehog signalling in cancer
T. Januario
Nature, 2008
View PDFchevron_right